National Institute of Dental & Craniofacial Research; Notice of Closed Meeting, 57098-57099 [2012-22768]
Download as PDF
<![CDATA[
57098
Federal Register / Vol. 77, No. 180 / Monday, September 17, 2012 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Population
Sciences and Epidemiology R15.
Date: October 1, 2012.
Time: 3:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Fungai Chanetsa, MPH,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3135,
MSC 7770, Bethesda, MD 20892, 301–408–
9436, fungai.chanetsa@nih.hhs.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Biology-1.
Date: October 10, 2012.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Angela Y Ng, MBA, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6200,
MSC 7804, Bethesda, MD 20892, 301–435–
1715, nga@csr.nih.gov.
Name of Committee:Center for Scientific
Review Special Emphasis Panel;
Collaborative Applications: Collaborative
Clinical and Services Studies.
Date: October 12, 2012.
Time: 12:00 p.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Hotel, 2033 M Street
NW., Washington, DC 20036.
Contact Person: Serena Chu, Ph.D.,
Scientific Review Officer, BBBP IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3178,
MSC 7848, Bethesda, MD 20892, 301–500–
5829, sechu@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Bioinformatics in Surgical Sciences,
Biomedical Imaging and Bioengineering.
Date: October 15, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Guo Feng Xu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5122,
MSC 7854, Bethesda, MD 20892, 301–237–
9870, xuguofen@csr.nih.gov.
Name of Committee: Vascular and
Hematology Integrated Review Group;
VerDate Mar<15>2010
19:43 Sep 14, 2012
Jkt 226001
Atherosclerosis and Inflammation of the
Cardiovascular System Study Section.
Date: October 15–16, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites O’Hare, Chicago,
5500 North River Road, Rosemont, IL 60018.
Contact Person: Anshumali Chaudhari,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4124,
MSC 7802, Bethesda, MD 20892, (301) 435–
1210, chaudhaa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Program
Project: Mouse Meiosis.
Date: October 15, 2012.
Time: 3:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Michael M. Sveda, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2204,
MSC 7890, Bethesda, MD 20892, 301–435–
3565, svedam@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group;
Pregnancy and Neonatology Study Section.
Date: October 16–17, 2012.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Michael Knecht, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6176,
MSC 7892, Bethesda, MD 20892, (301) 435–
1046, knechtm@csr.nih.gov.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Gene and Drug Delivery Systems
Study Section.
Date: October 16–17, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Handlery Union Square Hotel, 351
Geary Street, San Francisco, CA 94102.
Contact Person: Amy L Rubinstein, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5152,
MSC 7844, Bethesda, MD 20892, 301–408–
9754, rubinsteinal@csr.nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Cardiovascular and Sleep Epidemiology
Study Section.
Date: October 16, 2012.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Hotel, 2033 M Street
NW, Washington, DC 20036.
Contact Person: Julia Krushkal, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
Health, 6701 Rockledge Drive, Room 3148,
MSC 7770, Bethesda, MD 20892, 301–435–
1782, krushkalj@csr.nih.gov.
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group; Macromolecular Structure
and Function E Study Section.
Date: October 17, 2012.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Mayflower Hotel, 1127
Connecticut Avenue NW, Washington, DC
20036.
Contact Person: Nitsa Rosenzweig, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4152,
MSC 7760, Bethesda, MD 20892, (301) 435–
1747, rosenzweign@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 11, 2012.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–22770 Filed 9–14–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; Review of R34 Clinical Trial
or Biomarker Clinical Evaluation Study
Planning Grants.
Date: October 9, 2012.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
E:\FR\FM\17SEN1.SGM
17SEN1
57099
Federal Register / Vol. 77, No. 180 / Monday, September 17, 2012 / Notices
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Victor Henriquez, Ph.D.,
Scientific Review Officer, DEA/SRB/NIDCR,
6701 Democracy Blvd., Room 668, Bethesda,
MD 20892–4878, 301–451–2405,
henriquv@nidcr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: September 11, 2012.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–22768 Filed 9–14–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
mstockstill on DSK4VPTVN1PROD with NOTICES
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NHLBI Resource-Related Research Project for
Gene Targeted Rat Models.
Date: October 10, 2012.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Melissa E Nagelin, Ph.D.
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Rm.
7202, Bethesda, MD 20892, 301–435–0297,
nagelinmh2@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Mentoring Program to Promote Diversity in
Health Research.
Date: October 11, 2012.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, Conf. Room 10, 31 Center Drive,
Bethesda, MD 20892.
Contact Person: Stephanie L Constant,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute, 6701 Rockledge
Drive, Room 7189, Bethesda, MD 20892, 301–
443–8784, constantsl@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: September 11, 2012.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–22769 Filed 9–14–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: Treatment Episode Data Set
(TEDS)—New
The Treatment Episode Data Set
(TEDS) is a compilation of client-level
substance abuse treatment admission
and discharge data submitted by States
on clients treated in facilities that
receive State funds. TEDS is related to
SAMHSA’s Drug and Alcohol Services
Number of
respondents
Type of respondent and activity
Information System (DASIS) (now the
Behavioral Health Services Information
System (BHSIS)), and was previously
approved as part of the DASIS data
collection (OMB No. 0930–0106).
SAMHSA is now requesting OMB
approval for TEDS separately from the
other DASIS/BHSIS activities.
The BHSIS data collections involve
primarily facility-level data systems,
including the Inventory of Behavioral
Health Services (I–BHS), which is an
inventory of substance abuse and
mental health treatment facilities, the
National Survey of Substance Abuse
Treatment Services (N–SSATS), and the
National Mental Health Services Survey
(NMHSS, OMB No. 0930–0119). The
N–SSATS and NMHSS are census
surveys of treatment facilities. In
contrast, TEDS is a client-level data
system that collects admission and
discharge records from state substance
abuse agencies. Therefore, SAMHSA is
requesting OMB approval for the TEDS
client-level data collection separately
from the BHSIS facility-related
activities.
TEDS data are collected to obtain
information on the number of
admissions and discharges at publiclyfunded substance abuse treatment
facilities and on the characteristics of
clients receiving services at those
facilities. TEDS also monitors trends in
the demographic and substance use
characteristics of treatment admissions.
In addition, several of the data elements
used to calculate performance measures
for the Substance Abuse Prevention and
Treatment (SAPT) Block Grant are
collected in TEDS.
This request for OMB approval
includes a request to continue the
collection of TEDS client-level
admissions and discharge data. Most
states collect the TEDS data elements
from their treatment providers for their
own administrative purposes and are
able to submit a crossed-walked extract
of their data to TEDS. No significant
changes are expected in the TEDS
collection (other than recording the
TEDS burden hours separately from the
DASIS/BHSIS burden hours.)
Estimated annual burden for the
TEDS activities is shown below:
Responses
per
respondent
Hours per
response
Total burden
hours
STATES:
TEDS Admission Data ............................................................................
TEDS Discharge Data ............................................................................
TEDS Crosswalks ...................................................................................
52
52
5
4
4
1
6.25
8.25
10
1,300
1,716
50
Total .................................................................................................
52
........................
..........................
3,066
VerDate Mar<15>2010
19:43 Sep 14, 2012
Jkt 226001
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
E:\FR\FM\17SEN1.SGM
17SEN1
]]>Agencies
[Federal Register Volume 77, Number 180 (Monday, September 17, 2012)]
[Notices]
[Pages 57098-57099]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-22768]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Dental & Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Dental and Craniofacial
Research Special Emphasis Panel; Review of R34 Clinical Trial or
Biomarker Clinical Evaluation Study Planning Grants.
Date: October 9, 2012.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, One Democracy Plaza, 6701
Democracy
[[Page 57099]]
Boulevard, Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Victor Henriquez, Ph.D., Scientific Review
Officer, DEA/SRB/NIDCR, 6701 Democracy Blvd., Room 668, Bethesda, MD
20892-4878, 301-451-2405, henriquv@nidcr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral
Diseases and Disorders Research, National Institutes of Health, HHS)
Dated: September 11, 2012.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-22768 Filed 9-14-12; 8:45 am]
BILLING CODE 4140-01-P
